Stroke in Young Patients: 5 New Things
In young patients with stroke without a clear cause, physicians should search for less common etiologies and treat accordingly.
Dr Wilner is Associate Professor of Neurology at the University of Tennessee Health Science Center and a staff physician at Regional One Health in Memphis, TN. His upcoming book is The Locum Life: A Physician's Guide to Locum Tenens. Website:
Every four minutes, a person in the US dies of stroke. In fact, stroke is the fifth leading cause of death in the US, affecting more than 795,000 people per year. While the risk of stroke increases with age, approximately 1 in 3 patients
5 New Things
A
1. Risk factors have increased for this population.
In the younger population, the prevalence of stroke risk factors such as hypertension, hyperlipidemia, obesity and smoking has increased from 2004 to 2012, nearly doubling in some cases. Cocaine use, another stroke risk factor, has increased nearly six-fold in young adults with ischemic stroke. Even cannabis users have more than twice the risk of developing ischemic stroke.
2. Complications From patent foramen ovale
Patent foramen ovale (PFO) is a common condition occurring in 25% of the population. In a minority of these patients, paradoxical embolism may occur, which can result in stroke. Patients with large interatrial shunts and/or the presence of atrial septal aneurysm may benefit from percutaneous PFO closure in order to prevent recurrent stroke.
3. Higher link of cervical artery dissection with stroke in younger stroke patients.
Cervical artery dissection can be either spontaneous/result from a medical condition or traumatic. In the general population, it is a less common cause of stroke, linked to only 2% of all cases. A
4. Genetics plays a role.
In young adults with ischemic stroke, particularly those without traditional atherosclerotic risk factors such as hypertension and smoking, a genetic cause may be responsible. Screening for inherited monogenic disorders such as cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), cerebral amyloid angiopathy, Fabry disease, Marfan syndrome, and mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) should be considered, although the yield may be <10%.
Mortality and morbidity rates, treatment issues >
5. High rates of mortality and morbidity
Mortality after 10 years in young adults with stroke is 10 times higher than the general population. Not surprisingly, the rates are even higher for young adults who experience recurrent strokes. A large retrospective study found that more than half of these young patients are unable to return to work after a stroke. Issues such as depression, sexual dysfunction, fatigue, post-stroke pain, and cognitive dysfunction plays a role in the high mortality rates for these patients, and thus should be assessed and addressed.
Treatment Issues
The 2018 American Heart Association (AHA)/American Stroke Association (ASA) Guidelines for the Early Management of Patients with Acute Ischemic Stroke do not
In
Conclusions
Stroke in young adults is increasing in incidence. In many cases, it is the result of an increased frequency of modifiable conventional risk factors, such as hypertension, hyperlipidemia, obesity, and smoking, all of which may result in early atherosclerosis. In patients without traditional stroke risk factors, other etiologies for stroke should be considered, such as cardioembolism, cervical artery dissection, eclampsia, migraine with aura, inherited monogenic disorders, hypercoagulable state, and substance abuse.
Ischemic stroke in young adults aged 18 years or older should be treated according to AHA/ASA Guidelines. In young patients with stroke without a clear cause, physicians should search for less common etiologies and treat accordingly.
References:
1. Martinez-Majander N, Aarnia K, Pirinen J, et al.
2. Bhatt N, Malik AM, Chaturvedi S.
3. Nedeltchev K, der Maur TA, Georgiadis D, et al.
4. Powers WJ, Rabinstein AA, Ackerson T, et al.
5. Alebeek MEV, Arntz RM, Ekker MS et al.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
- Perispinal Etanercept Shows No Efficacy in Treating Chronic Stroke
September 16th 2025